Nonselective cation channel blocking drugs, such as quinidine and bepridil, have been shown to inhibit KCNT1 channels in in vitro experiments,31, 43 with quinidine having been trialed as a stratified treatment for KCNT1 epilepsy.44, 45, 46, 47. The gene discussed is KCNT1; the disease is epilepsy.